MTOR and autoimmune disease: Rapamycin is a macrocyclic antibiotic that blocks the multifunctional serine-threonine kinase, as an inhibitor of the mammalian target of rapamycin (mTOR) pathway that has been used to treat autoimmune diseases and to prevent rejection in solid organ and hematopoietic stem cell transplantation diseases [6, 7].